Showing results (1561-1570 of 1,598) with videos related to
Sort By:
Pageof 160
World Journal of Gastroenterology|November 29, 2024
Prognostic impact and reasons for variability by tumor location in gastric cancerYi-Xing Huang, Han-Yi He, Ken Chen, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 9, 2024
Anti-CTLA-4 m2a Antibody Exacerbates Cardiac Injury in Experimental Autoimmune Myocarditis Mice By Promoting Ccl5-Neutrophil InfiltrationMing-Ming Wu, Yan-Chao Yang, Yong-Xu Cai, et al.Journal of Autoimmunity|September 23, 2018
T follicular helper cells restricted by IRF8 contribute to T cell-mediated inflammationRuihua Zhang, Chen-Feng Qi, Yuan Hu, et al.Scientific Reports|April 16, 2026
Comparison of the long-term impact of laparoscopy and open surgery on the prognosis of patients with locally advanced gastric cancerMing-Cong Deng, Ken Chen, Qi-Mei Bao, et al.The European Respiratory Journal|December 23, 2018
Germline BMP9 mutation causes idiopathic pulmonary arterial hypertensionXiao-Jian Wang, Tian-Yu Lian, Xin Jiang, et al.British Journal of Haematology|May 26, 2018
Transcriptomic rationale for synthetic lethality-targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemiaAna M Hurtado, Gines Luengo-Gil, Tzu H Chen-Liang, et al.Biorxiv : the Preprint Server for Biology|April 15, 2024
Ontology-based modeling, integration, and analysis of heterogeneous clinical, pathological, and molecular kidney data for precision medicineYongqun Oliver He, Laura Barisoni, Avi Z Rosenberg, et al.Cancer Letters|July 6, 2026
FGFR2 Fusion-Driven CXCL3 Downregulation Attenuates Neutrophil Recruitment in Intrahepatic CholangiocarcinomaTao Zhu, Jia-Cheng Lu, Yan-Zi Pei, et al.Human Mutation|February 10, 2022
Genome sequencing demonstrates high diagnostic yield in children with undiagnosed global developmental delay/intellectual disability: A prospective studyYu Sun, Jing Peng, Desheng Liang, et al.Therapeutic Advances in Hematology|October 6, 2022
Relevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents: a cohort study from the GESMDLaura Vilorio-Marqués, Christelle Castañón Fernández, Elvira Mora, et al.Pageof 160